BeStock  
Stocks › Biotechnology › GERN

Geron GERN

US equityMarket cap rank #3527Biotechnology
$0.87 −$0.04 (-4.63%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $0.89 +2.45%
Open$0.89
Prev close$0.91
Day range$0.86 – $0.93
Volume13.83M
Market cap$560.94M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership74.1%-0.76 pts vs. prior quarter
Institutions holding295+0 vs. prior quarter
Insider trades (recent)46 buys / 3 sellsNet buying
Short interest10.42% of floatDays to cover 3.9 · as of 30 Oct 2026
Short-sale volume share13.6%5-day average of daily volume

Short-sale volume as % of daily volume

2%10%18%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$9.39M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$10.3MSuper+$919.0KBig+$878.7KMid−$903.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 30.6% of shares outstanding.

Largest holders

  • BlackRock7.85%
  • RA Capital Management, L.P.6.65%
  • Soleus Capital Management, L.P.6.64%
  • State Street Global Advisors4.95%
  • Citadel Advisors LLC4.51%
  • Vanguard Capital Management, LLC4.30%
  • ClearBridge Investments, LLC3.05%
  • Eversept Partners, L.P.2.91%

By investor type

  • Mutual Fund34.95%
  • Hedge Fund22.41%
  • VC/PE Fund9.16%
  • Public Company6.03%
  • Private Company0.92%
  • Insurance Company0.30%
  • Government Pension Fund0.27%
  • Individual/Insider0.08%

Reported short interest has fallen from 12.55% to 10.42% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q3 +2,393,786 1.2%
PanAgora Asset Management, Inc. Mutual Fund 2026/Q3 +1,818,004 0.7%
BlackRock Mutual Fund 2026/Q3 +1,452,104 7.8%
Franklin Resources Mutual Fund 2026/Q3 +880,614 0.2%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +687,126 0.2%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +496,840 0.1%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +457,674 0.1%
Citadel Advisors LLC Hedge Fund 2026/Q3 +7,462,359 4.5%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +6,143,815 1.7%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +5,370,752 2.5%
State Street Global Advisors Mutual Fund 2026/Q3 +5,359,488 5.6%
The Toronto-Dominion Bank Public Company 2026/Q3 +4,107,289 0.7%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +2,779,479 0.7%
PanAgora Asset Management, Inc. Mutual Fund 2026/Q3 +2,578,624 0.5%
ExodusPoint Capital Management, LP Hedge Fund 2026/Q3 +2,514,158 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
29 Sep 2026 Robert Jay Spiegel Independent Director Other Acquisition +6,351 $1.23 212,161
29 Jun 2026 Robert Jay Spiegel Independent Director Other Acquisition +6,103 $1.28 205,810
19 May 2026 Elizabeth O'Farrell Independent Chairperson Other Derivative Acquisition +220,000 $1.26 220,000
19 May 2026 Robert Jay Spiegel Independent Director Other Derivative Acquisition +220,000 $1.26 220,000
19 May 2026 Susan Molineaux Independent Director Other Derivative Acquisition +220,000 $1.26 220,000
19 May 2026 John McDonald Independent Director Other Derivative Acquisition +220,000 $1.26 220,000
19 May 2026 Dawn Bir Independent Director Other Derivative Acquisition +220,000 $1.26 220,000
12 Apr 2026 Timothy Williams Executive Vice President Other Derivative Acquisition +2,500,000 $1.73 2,500,000
30 Mar 2026 Robert Jay Spiegel Independent Director Other Acquisition +5,243 $1.49 199,707
24 Mar 2026 Patricia Susan Andrews Independent Director Other Derivative Acquisition +270,000 $1.57 270,000
24 Mar 2026 Constantine Chinoporos Independent Director Other Derivative Acquisition +270,000 $1.57 270,000
17 Feb 2026 Michelle Robertson EVP, CFO, Treasurer and Principal Financial & Accounting Officer Derivative Exercise and Sale -9,855 $1.94 17,645
17 Feb 2026 Michelle Robertson EVP, CFO, Treasurer and Principal Financial & Accounting Officer Derivative Exercise and Retained +17,645 – 17,645
16 Feb 2026 Joseph Eiden Other Derivative Acquisition +2,220,000 $1.80 2,220,000
16 Feb 2026 Michelle Robertson EVP, CFO, Treasurer and Principal Financial & Accounting Officer Other Derivative Acquisition +1,660,000 $1.80 1,660,000
30 Dec 2025 Robert Jay Spiegel Independent Director Other Acquisition +5,918 $1.32 194,464
14 Dec 2025 James Ziegler Former Executive Vice President Intent to Sell (Form 144) -20,000 $1.37 –
19 Oct 2025 Ahmed ElNawawi Executive Vice President Other Derivative Acquisition +3,000,000 $1.27 3,000,000
19 Oct 2025 Ahmed ElNawawi Executive Vice President Initial Statement of Beneficial +0 – 10,000
29 Sep 2025 Robert Jay Spiegel Independent Director Other Acquisition +5,702 $1.37 188,546

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 66,951,283 10.4% 3.9
15 Oct 2026 74,608,604 11.6% 9.9
30 Sep 2026 73,886,113 11.5% 7.4
15 Sep 2026 82,618,677 12.9% 6.7
31 Aug 2026 85,093,515 13.2% 11.0
14 Aug 2026 80,600,696 12.5% 5.8

Discussion

No comments yet — be the first to weigh in on GERN.

Sign in to join the discussion.

Scroll to Top